Abstract
Summary A study of phosphate components in experimental atherosclerotic plaque reversal of the rabbit aorta reveals a shorter half-life for total aortic phosphate, phospholipid phosphorus, and TCA-soluble phosphate in MgEDTA-treated animals compared to normal and atherosclerotic controls. In MgEDTA-treated animals these phosphorus components in absolute amounts lie well between that of the normal and untreated atherosclerotic animal.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
